Hyperuricemia, the heart, and the kidneys - to treat or not to treat?


Journal

Renal failure
ISSN: 1525-6049
Titre abrégé: Ren Fail
Pays: England
ID NLM: 8701128

Informations de publication

Date de publication:
Nov 2020
Historique:
entrez: 25 9 2020
pubmed: 26 9 2020
medline: 22 7 2021
Statut: ppublish

Résumé

Hyperuricemia is a state in which the serum levels of uric acid are elevated. As such it has a pronounced effect on vascular and renal function with their consequences, while also showing some antioxidant effects that show to be beneficial. Hyperuricemia has shown to have a J-shaped relationship with mortality, is frequently associated with development and progression of heart and kidney disease, and is correlated with malnutrition-inflammation-atherosclerosis syndrome, although several Mendelian studies have failed to show an association with morbidity and mortality. Hyperuricemia is usually associated with gout flares and tophi development but can also present as asymptomatic hyperuricemia. It is still uncertain whether asymptomatic hyperuricemia is an independent risk factor for cardiovascular or renal disease and as such its treatment is questionable. Some possible tools for future decision making are the use of noninvasive techniques such as pulse wave analysis, urinary sediment analysis, and joint ultrasound, which could help identify individuals with asymptomatic hyperuricemia that could benefit from urate lowering therapy most.

Sections du résumé

BACKGROUND BACKGROUND
Hyperuricemia is a state in which the serum levels of uric acid are elevated. As such it has a pronounced effect on vascular and renal function with their consequences, while also showing some antioxidant effects that show to be beneficial.
SUMMARY CONCLUSIONS
Hyperuricemia has shown to have a J-shaped relationship with mortality, is frequently associated with development and progression of heart and kidney disease, and is correlated with malnutrition-inflammation-atherosclerosis syndrome, although several Mendelian studies have failed to show an association with morbidity and mortality. Hyperuricemia is usually associated with gout flares and tophi development but can also present as asymptomatic hyperuricemia. It is still uncertain whether asymptomatic hyperuricemia is an independent risk factor for cardiovascular or renal disease and as such its treatment is questionable.
KEY MESSAGES CONCLUSIONS
Some possible tools for future decision making are the use of noninvasive techniques such as pulse wave analysis, urinary sediment analysis, and joint ultrasound, which could help identify individuals with asymptomatic hyperuricemia that could benefit from urate lowering therapy most.

Identifiants

pubmed: 32972284
doi: 10.1080/0886022X.2020.1822185
pmc: PMC7534372
doi:

Substances chimiques

Uric Acid 268B43MJ25

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

978-986

Références

Rheumatology (Oxford). 2018 Dec 1;57(12):2145-2148
pubmed: 30085130
Clin Exp Nephrol. 2020 Mar;24(Suppl 1):1-5
pubmed: 31754883
High Blood Press Cardiovasc Prev. 2020 Apr;27(2):121-128
pubmed: 32157643
PLoS One. 2017 Jan 20;12(1):e0170393
pubmed: 28107415
Diabetes Care. 2019 Jun;42(6):1088-1094
pubmed: 30885950
PLoS One. 2018 Jul 2;13(7):e0199865
pubmed: 29966019
Curr Hypertens Rep. 2016 Oct;18(10):74
pubmed: 27696189
Hypertension. 2019 Jul;74(1):95-101
pubmed: 31079535
Dis Markers. 2019 Apr 03;2019:4578327
pubmed: 31281547
Nephrol Dial Transplant. 2013 Sep;28(9):2221-8
pubmed: 23543594
Curr Rheumatol Rep. 2016 Jun;18(6):34
pubmed: 27105641
Cardiovasc Ther. 2018 Aug;36(4):e12432
pubmed: 29673103
Am J Nephrol. 2017;45(5):452-459
pubmed: 28463849
Diabetes Obes Metab. 2018 Feb;20(2):458-462
pubmed: 28846182
Kidney Blood Press Res. 2018;43(2):606-615
pubmed: 29689561
Rheumatol Int. 2010 Feb;30(4):495-503
pubmed: 19543895
J Atheroscler Thromb. 2017 Jun 1;24(6):630-642
pubmed: 27784849
Cardiovasc Ther. 2016 Dec;34(6):441-449
pubmed: 27542348
Clin Exp Nephrol. 2018 Dec;22(6):1324-1330
pubmed: 29761242
Am J Transl Res. 2020 Jul 15;12(7):3167-3181
pubmed: 32774692
Am J Kidney Dis. 2018 Mar;71(3):362-370
pubmed: 29132945
Mod Rheumatol. 2017 May;27(3):518-523
pubmed: 27492663
Int Urol Nephrol. 2019 Mar;51(3):467-473
pubmed: 30604229
Medicine (Baltimore). 2018 Mar;97(13):e0161
pubmed: 29595642
Drug Res (Stuttg). 2016 Dec;66(12):628-632
pubmed: 27643410
Ann Rheum Dis. 2012 Jan;71(1):157-8
pubmed: 21953340
Int J Cardiol. 2016 Jun 15;213:8-14
pubmed: 26316329
Am J Med. 1987 Mar;82(3):421-6
pubmed: 3826098
Am J Kidney Dis. 2017 Aug;70(2):158-159
pubmed: 28739125
Clin Exp Nephrol. 2018 Dec;22(6):1300-1308
pubmed: 29700702
Nephrourol Mon. 2015 May 23;7(3):e27233
pubmed: 26290849
Reumatologia. 2018;56(2):106-110
pubmed: 29853726
Arthritis Res Ther. 2014 Mar 04;16(2):R60
pubmed: 24588936
Ann Intern Med. 2020 Feb 4;172(3):186-194
pubmed: 31931526
Eur J Med Chem. 2017 Jul 28;135:491-516
pubmed: 28478180
J Adv Res. 2017 Sep;8(5):551-554
pubmed: 28748121
Oncotarget. 2017 Sep 19;8(46):80688-80699
pubmed: 29113336
BMC Med. 2017 Jul 3;15(1):123
pubmed: 28669352
Adv Chronic Kidney Dis. 2012 Nov;19(6):386-91
pubmed: 23089273
Acta Med Croatica. ;70(4-5):233-9
pubmed: 29087102
J Huazhong Univ Sci Technolog Med Sci. 2014 Aug;34(4):476-481
pubmed: 25135714
Sci Rep. 2017 Aug 18;7(1):8822
pubmed: 28821853
Pharmacol Res. 2015 Dec;102:63-70
pubmed: 26384444
Nucleosides Nucleotides Nucleic Acids. 2011 Dec;30(12):1039-44
pubmed: 22132954
Hypertension. 2017 Jun;69(6):1036-1044
pubmed: 28396536
Curr Med Res Opin. 2017 Nov;33(sup3):9-13
pubmed: 28952391
JAMA Intern Med. 2018 Nov 1;178(11):1526-1533
pubmed: 30304329
Clin Exp Nephrol. 2019 Mar;23(3):362-370
pubmed: 30291473
Kidney Res Clin Pract. 2017 Dec;36(4):368-376
pubmed: 29285429
Clin Rheumatol. 2014 Nov;33(11):1643-8
pubmed: 25048744
Curr Opin Rheumatol. 2014 Mar;26(2):186-91
pubmed: 24419750
J Cardiovasc Transl Res. 2019 Jun;12(3):204-210
pubmed: 30414068
Clin J Am Soc Nephrol. 2011 Oct;6(10):2470-7
pubmed: 21868616
J Adv Res. 2017 Sep;8(5):555-560
pubmed: 28748122
Curr Rheumatol Rep. 2015 Mar;17(3):13
pubmed: 25740704
N Engl J Med. 2018 Mar 29;378(13):1200-1210
pubmed: 29527974
Ann Rheum Dis. 2017 Jan;76(1):29-42
pubmed: 27457514
Clin Chim Acta. 2018 Nov;486:156-161
pubmed: 30076802
Am J Physiol Renal Physiol. 2008 Oct;295(4):F1134-41
pubmed: 18701632
Pharm Biol. 2016 Dec;54(12):3151-3155
pubmed: 27563755
Expert Opin Investig Drugs. 2018 May;27(5):437-444
pubmed: 29718730
Hemodial Int. 2015 Oct;19(4):514-20
pubmed: 25998500
Eur Heart J. 2019 Jun 7;40(22):1778-1786
pubmed: 30844048
Ther Adv Cardiovasc Dis. 2017 Feb;11(2):57-62
pubmed: 27932570
BMC Cardiovasc Disord. 2018 Feb 7;18(1):24
pubmed: 29415653
Adv Rheumatol. 2019 Aug 7;59(1):37
pubmed: 31391099
Int Urol Nephrol. 2019 Jun;51(6):1013-1018
pubmed: 31020628
Int J Clin Pharmacol Ther. 2018 Jul;56(7):321-327
pubmed: 29750634
Heart Fail Rev. 2020 Jan;25(1):43-51
pubmed: 31745840
Drugs. 2016 Jun;76(9):947-56
pubmed: 27260336
Nephrol Dial Transplant. 2018 Sep 1;33(9):1620-1627
pubmed: 29165620
Biol Pharm Bull. 2014;37(2):226-31
pubmed: 24492719
BMC Microbiol. 2020 Jul 6;20(1):195
pubmed: 32631233
Eur J Intern Med. 2020 Apr;74:8-17
pubmed: 31952982
Clin Nephrol. 2017 Supplement 1;88(13):69-72
pubmed: 28601125
Brain Disord Ther. 2013 Nov 1;2(2):109
pubmed: 24511458
Am J Kidney Dis. 2015 Dec;66(6):945-50
pubmed: 26233732
South Med J. 2014 Apr;107(4):235-41
pubmed: 24937517
Semin Arthritis Rheum. 2017 Feb;46(4):457-464
pubmed: 27591828
PLoS One. 2018 Aug 24;13(8):e0202901
pubmed: 30142173
PLoS One. 2012;7(2):e30456
pubmed: 22348008
Saudi J Kidney Dis Transpl. 2018 Sep-Oct;29(5):1050-1056
pubmed: 30381500
PLoS One. 2018 Nov 1;13(11):e0206850
pubmed: 30383816
Nephrology (Carlton). 2018 Nov;23(11):1023-1030
pubmed: 28990729
Drugs. 2018 Jan;78(1):99-109
pubmed: 29139092
BMC Nephrol. 2014 Jul 27;15:122
pubmed: 25064611
Clin Rheumatol. 2017 Dec;36(12):2637-2644
pubmed: 28980141
Eur J Heart Fail. 2018 Mar;20(3):514-522
pubmed: 29193563
Mod Rheumatol. 2019 Sep;29(5):880-884
pubmed: 30175646
Joint Bone Spine. 2019 Jul;86(4):437-443
pubmed: 30316974
Clin Rheumatol. 2020 Nov;39(11):3287-3294
pubmed: 32418037
Oxid Med Cell Longev. 2019 Sep 15;2019:4584936
pubmed: 31636804
Am J Kidney Dis. 2018 Dec;72(6):798-810
pubmed: 30177485
Intern Med J. 2021 May;51(5):752-762
pubmed: 32149437

Auteurs

Tadej Petreski (T)

Department of Nephrology, Clinic for Internal Medicine, University Medical Centre Maribor, Maribor, Slovenia.
Faculty of Medicine, University of Maribor, Maribor, Slovenia.

Robert Ekart (R)

Faculty of Medicine, University of Maribor, Maribor, Slovenia.
Department of Dialysis, Clinic for Internal Medicine, University Medical Centre Maribor, Maribor, Slovenia.

Radovan Hojs (R)

Department of Nephrology, Clinic for Internal Medicine, University Medical Centre Maribor, Maribor, Slovenia.
Faculty of Medicine, University of Maribor, Maribor, Slovenia.

Sebastjan Bevc (S)

Department of Nephrology, Clinic for Internal Medicine, University Medical Centre Maribor, Maribor, Slovenia.
Faculty of Medicine, University of Maribor, Maribor, Slovenia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH